品牌价值-最有价值和最强大的医药、医疗器械和医疗服务品牌的年度报告（英）-2022.5-42页_5mb

2022 Healthcare Brand Value Report Summary

Core Content

The 2022 Brand Finance report highlights the financial performance and brand strength of leading pharmaceutical, medical devices, and healthcare services brands. The report emphasizes the role of strong brands in driving profitability and their importance in the healthcare sector, especially during the global impact of the COVID-19 pandemic.

Main Points

Pharmaceutical Brands

• Johnson & Johnson retains the top position with a brand value of US$13.4 billion, up 24.4% from 2021.
• Pfizer holds the strongest pharmaceutical brand with an AAA Brand Strength Index (BSI) rating, and its brand value increased to US$6.3 billion, up 58%.
• AstraZeneca is the fastest-growing pharmaceutical brand in 2022, with a 77% increase in brand value to US$5.6 billion, largely due to its COVID-19 vaccine development and deployment.
• Guangzhou Pharmaceutical (China) achieved 147% brand value growth over the past two years, reaching US$2.1 billion in 2021.

Medical Devices Brands

• Medtronic remains the most valuable medical devices brand at US$8.3 billion, despite a 10.2% decrease in brand value.
• Align is the fastest-growing medical devices brand, with a 67% increase in brand value to US$2.297 billion.
• Abbott is named the strongest medical devices brand with an AA rating and a BSI score of 73.9.
• The report notes that demand for medical devices surged during the pandemic, and brands demonstrated their ability to use global networks for sustainability and accessibility.

Healthcare Services Brands

• UnitedHealthcare is the most valuable and strongest healthcare services brand with a brand value of US$32.9 billion and an AA+ strength rating.
• IQVIA is the fastest-growing healthcare services brand, with a 47% increase in brand value.
• AmerisourceBergen is a new entrant to the top ten healthcare brands, valued at US$4.8 billion.

Key Information

• Brand Finance is the leading brand valuation consultancy, offering a unique blend of marketing and financial expertise.

• The report underscores the importance of brand value in driving business performance and profitability.

• ISO 10668 and ISO 20671 standards are used to evaluate brand value and strength, ensuring technical credibility.

• The global pharmaceutical industry played a critical role in combating the pandemic, with brand values surging due to their impact and recognition.

• Brand Value by Country for pharmaceutical brands:

  • United States: 46.5% of total value
  • Switzerland: 13.6%
  • United Kingdom: 10.7%
  • China: 9.9%
  • Germany: 7.9%

• Brand Value by Country for medical devices brands:

  • United States: 71.0%
  • Germany: 18.0%
  • Japan: 3.0%
  • United Kingdom: 3.0%
  • Switzerland: 2.0%
  • Denmark: 2.0%
  • France: 1.0%

• Brand Finance provides Brand Value Reports that offer insights into brand performance and help in strategic decision-making, including licensing, selling, and rebranding.

Conclusion

The 2022 report illustrates the strong financial performance of healthcare brands, particularly in the pharmaceutical and medical devices sectors, driven by innovation, pandemic response, and global reach. It also highlights the importance of brand strength in maximizing returns and the role of Brand Finance in bridging the gap between marketing and finance through credible and comprehensive brand valuation services.